The article mentions that six analysts have provided bullish ratings for Anixa Biosciences (ANIX) in the last quarter. The average 12-month price target has increased by 15.79% from the previous average, which indicates a positive sentiment towards the stock. This is likely to have a short-term positive impact on the stock price.